Article
Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease: Analysis of circular dichroism spectra

https://doi.org/10.1016/0022-2836(92)90106-TGet rights and content

Abstract

The A4 or β-peptide (39 to 43 amino acid residues) is the principal proteinaceous component of amyloid deposits in Alzheimer's disease. Using circular dichroism (c.d.), we have studied the secondary structures and aggregational properties in solution of 4 synthetic amyloid β-peptides: β-(1–28), β-(1–39), β-(1–42) and β-(29–42). The natural components of cerebrovascular deposits and extracellular amyloid plaques are β-(1–39) and β-(1–42), while β-(1–28) and β-(29–42) are unnatural fragments.

The β-(1–28), β-(1–39) and β-(1–42) peptides adopt mixtures of β-sheet, α-helix and random coil structures, with the relative proportions of each secondary structure being strongly dependent upon the solution conditions. In aqueous solution, β-sheet structure is favored for the β-(1–39) and β-(1–42) peptides, while in aqueous solution containing trifluoroethanol (TFE) or hexafluoroisopropanol (HFIP), α-helical structure is favored for all 3 peptides. The α-helical structure unfolds with increasing temperature and is favored at pH 1 to 4 and pH 7 to 10; the β-sheet conformation is temperature insensitive and is favored at pH 4 to 7. Peptide concentration studies showed that the β-sheet conformation is oligomeric (intermolecular), whereas the α-helical conformation is monomeric (intramolecular). The rate of aggregation to the oligomeric β-sheet structure (α-helix → random coil → β-sheet) is also dependent upon the solution conditions such as the pH and peptide concentration; maximum β-sheet formation occurs at pH 5.4. These results suggest that β-peptide is not an intrinsically insoluble peptide. Thus, solution abnormalities, together with localized high peptide concentrations, which may occur in Alzheimer's disease, may contribute to the formation of amyloid plaques.

The hydrophobic β-(29–42) peptide adopts exclusively an intermolecular β-sheet conformation in aqueous solution despite changes in temperature or pH. Therefore, this segment may be the first region of the β-peptide to aggregate and may direct the folding of the complete β-peptide to produce the β-pleated sheet structure found in amyloid deposits. Differences between the solution conformations of the β-(1–39) and β-(1–42) peptides suggests that the last 3 C-terminal amino acids are crucial to amyloid deposition.

References (71)

  • G.G. Glenner et al.

    Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

    Biochem. Biophys. Res. Commun

    (1984)
  • G.G. Glenner et al.

    Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein

    Biochem. Biophys. Res. Commun

    (1984)
  • C. Hilbich et al.

    Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

    J. Mol. Biol

    (1991)
  • D.G. Johnston et al.

    Acid-base balance in metabolic acidoses

  • N. Kitaguchi et al.

    Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: different properties compared with protease nexin-I

    Biochim. Biophys. Acta

    (1990)
  • U. Mönning et al.

    Synthesis and secretion of Alzheimer amyloid βA4 precursor protein by stimulated human peripheral blood leucocytes

    FEBS Letters

    (1990)
  • T. Oltersdorf et al.

    The Alzheimer's amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway

    J. Biol. Chem

    (1990)
  • F. Prelli et al.

    Differential processing of Alzheimer's β-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type

    Biochem. Biophys. Res. Commun

    (1988)
  • B.K. Siesjö

    Acid-base homeostasis in the brain: physiology, chemistry, and neurochemical pathology

  • A. Sillero et al.

    Isoelectric points of proteins: thereotical determination

    Anal. Biochem

    (1989)
  • F. Tagliavini et al.

    Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals

    Neurosci. Letters

    (1988)
  • H.M. Wisniewski et al.

    Ageing of the brain and dementia

    Trends NeuroSci

    (1980)
  • J.T. Yang et al.

    Calculation of protein conformation from circular dichroism

    Methods Enzymol

    (1986)
  • D. Allsop et al.

    Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid β-protein precursor of Alzheimer's disease

  • C.J. Barrow et al.

    Solution structures of β peptide and its constituent fragments: relation to amyloid deposition

    Science

    (1991)
  • N. Behrouz et al.

    Methods in laboratory investigation, Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance

    Lab. Invest. U.S.A

    (1989)
  • A. Bierzynski et al.

    A salt bridge stabilizes the helix formed by isolated C-peptide of RNase A

  • W. Braun et al.

    Conformation of glucagon in a lipid-water interphase by proton nuclear magnetic resonance

    J. Mol. Biol

    (1983)
  • E.M. Castano et al.

    Human amyloidosis, Alzheimer's disease and related disorders

    Lab. Invest

    (1988)
  • A.M. Cataldo et al.

    Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain

  • F. Coria et al.

    Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenetically related to Alzheimer's disease β-protein

    Amer. J. Path

    (1988)
  • T. Dyrks et al.

    Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease

    EMBO J

    (1988)
  • J. Dyson et al.

    Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix

    J. Mol. Biol

    (1988)
  • F. Esch et al.

    Cleavage of amyloid β-peptide during constitutive processing of its precursor

    Science

    (1990)
  • P.E. Fraser et al.

    Morphology and antibody recognition of synthetic β-amyloid peptides

    J. Neurosci. Res

    (1991)
  • Cited by (0)

    Present address: Sterling Drug Inc., 9 Great Valley Parkway, Malvern, PA 19355, U.S.A.

    View full text